Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-02 Sale | 2025-12-04 6:18 pm | Werewolf Therapeutics Inc. | HOWL | GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC Former 10% Owner | 199,732 | $0.91761 | $183,275 | 4,784,111 (Indirect) | View |
| 2025-11-26 Sale | 2025-12-01 6:11 pm | Werewolf Therapeutics Inc. | HOWL | GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner | 141,927 | $0.96426 | $136,855 | 4,983,843 (Indirect) | View |
| 2025-11-21 Sale | 2025-11-25 6:03 pm | Werewolf Therapeutics Inc. | HOWL | GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner | 195,666 | $0.91764 | $179,551 | 5,125,770 (Indirect) | View |
| 2025-11-18 Sale | 2025-11-20 5:50 pm | Werewolf Therapeutics Inc. | HOWL | GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner | 160,103 | $0.92386 | $147,913 | 5,321,436 (Indirect) | View |
| 2025-11-13 Sale | 2025-11-17 7:20 pm | Werewolf Therapeutics Inc. | HOWL | GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner | 209,652 | $0.95713 | $200,665 | 5,481,539 (Indirect) | View |
| 2025-11-07 Sale | 2025-11-12 7:31 pm | Werewolf Therapeutics Inc. | HOWL | GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner | 213,529 | $1.13 | $241,278 | 5,691,191 (Indirect) | View |
| 2025-11-04 Sale | 2025-11-06 7:40 pm | Werewolf Therapeutics Inc. | HOWL | GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner | 242,890 | $1.2178 | $295,781 | 5,904,720 (Indirect) | View |
| 2025-10-30 Sale | 2025-11-03 7:07 pm | Werewolf Therapeutics Inc. | HOWL | GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner | 295,043 | $1.3274 | $391,636 | 6,147,610 (Indirect) | View |
| 2025-10-27 Sale | 2025-10-29 7:21 pm | Werewolf Therapeutics Inc. | HOWL | GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner | 276,017 | $1.6173 | $446,403 | 6,442,653 (Indirect) | View |
| 2025-05-13 Sale | 2025-05-15 5:34 pm | iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT MPM BioImpact LLC Oncology Impact Fund (Cayman) Management L.P. UBS Oncology Impact Fund L.P. Former 10% Owner | 1,031,931 | $8.06 | $8,317,364 | 3,452,797 (Indirect) | View |
| 2025-03-27 Sale | 2025-04-30 4:08 pm | Werewolf Therapeutics Inc. | HOWL | GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner | 4,386 | $1.05 | $4,605 | 6,718,670 (Indirect) | View |
| 2022-01-04 Sale | 2022-01-06 4:12 pm | iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner | 245,469 | $42.58 | $10,452,334 | 4,484,728 (Indirect) | View |
| 2021-12-03 Sale | 2021-12-07 6:33 pm | iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner | 83,390 | $33.73 | $2,812,428 | 4,730,197 (Indirect) | View |
| 2021-11-30 Sale | 2021-12-02 6:53 pm | iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner | 139,773 | $34.47 | $4,817,417 | 4,813,587 (Indirect) | View |
| 2021-11-26 Sale | 2021-11-30 4:49 pm | iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner | 38,566 | $35.18 | $1,356,825 | 4,953,360 (Indirect) | View |
| 2021-11-22 Sale | 2021-11-24 6:38 pm | iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner | 129,617 | $36.61 | $4,744,666 | 5,007,597 (Indirect) | View |
| 2021-10-15 Sale | 2021-10-18 4:33 pm | iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner | 28,615 | $27.45 | $785,384 | 5,137,214 (Indirect) | View |
| 2021-10-12 Sale | 2021-10-14 5:26 pm | iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner | 95,002 | $27.21 | $2,584,606 | 5,165,829 (Indirect) | View |
| 2021-10-07 Sale | 2021-10-12 4:33 pm | iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner | 87,006 | $27.23 | $2,368,800 | 5,260,831 (Indirect) | View |
| 2021-10-01 Sale | 2021-10-05 4:31 pm | iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner | 46,130 | $27.05 | $1,247,590 | 5,347,837 (Indirect) | View |
| 2021-09-28 Sale | 2021-09-30 5:05 pm | iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner | 35,990 | $27 | $971,730 | 5,393,967 (Indirect) | View |
| 2021-09-23 Sale | 2021-09-27 5:51 pm | iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner | 89,476 | $27.76 | $2,484,094 | 5,429,957 (Indirect) | View |
| 2021-09-21 Sale | 2021-09-23 4:18 pm | iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner | 56,779 | $27.5 | $1,561,394 | 5,519,433 (Indirect) | View |
| 2021-09-16 Sale | 2021-09-20 6:30 pm | iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner | 152,711 | $28.38 | $4,334,452 | 5,576,212 (Indirect) | View |
| 2021-09-16 Sale | 2021-09-20 5:31 pm | Cullinan Oncology Inc. | CGEM | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. BioImpact Capital LLC 10% Owner | 3,124 | $29.06 | $90,783 | 7,648,268 (Direct) | View |
| 2021-09-14 Sale | 2021-09-16 4:46 pm | iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner | 76,417 | $27.7 | $2,116,733 | 5,728,923 (Indirect) | View |
| 2021-09-14 Sale | 2021-09-16 4:45 pm | Cullinan Oncology Inc. | CGEM | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. BioImpact Capital LLC 10% Owner | 13,531 | $29.17 | $394,635 | 7,651,392 (Direct) | View |
| 2021-09-09 Sale | 2021-09-13 7:02 pm | iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner | 96,456 | $28.32 | $2,731,460 | 5,805,340 (Indirect) | View |
| 2021-09-09 Sale | 2021-09-13 6:24 pm | Cullinan Oncology Inc. | CGEM | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. BioImpact Capital LLC 10% Owner | 23,253 | $29.23 | $679,738 | 7,664,923 (Direct) | View |
| 2021-09-07 Sale | 2021-09-08 7:19 pm | iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner | 71,232 | $29.03 | $2,067,786 | 5,933,136 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-27 Exercise | 2025-04-30 4:08 pm | N/A 2025-04-09 | Werewolf Therapeutics Inc. | HOWL | GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner | 50,873 | $0 | 6,718,670 (Indirect) | View |
| 2025-03-27 Exercise | 2025-04-30 4:08 pm | N/A N/A | Werewolf Therapeutics Inc. | HOWL | GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner | 50,873 | $0.09 | 6,718,670 (Indirect) | View |
| 2023-06-01 Other | 2023-06-05 4:37 pm | N/A N/A | TCR2 THERAPEUTICS INC. | TCRR | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. BioImpact Capital LLC 10% Owner | 3,370,982 | $0 | 3,370,982 (Direct) | View |
| 2021-11-17 Other | 2021-11-24 6:38 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner | 15,671 | $0 | 5,007,597 (Indirect) | View |
| 2021-09-07 Other | 2021-09-08 7:19 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT UBS Oncology Impact Fund L.P. BioImpact Capital LLC Oncology Impact Fund (Cayman) Management L.P. 10% Owner | 31,340 | $0 | 5,933,136 (Indirect) | View |